Académique Documents
Professionnel Documents
Culture Documents
Healthline.
(2017). Understandin
g the ‘AIDS Cocktail’.
[online]
• NUCLEOSIDE REVERSE TRANSCRIPTASE
INHIBITORS (NRTIS): THE HIV VIRUS REQUIRES
REVERSE TRANSCRIPTASE (RT) IN ORDER TO
REPLICATE. BY OFFERING FAULTY VERSIONS
OF THE BUILDING BLOCKS FOR REPLICATION
TO THE VIRUSES, THE DRUG THERAPY WORKS
TO BLOCK THE VIRUS’S ABILITY TO
REPLICATE.
• NON-NUCLEOSIDE REVERSE TRANSCRIPTION
INHIBITORS (NNRTIS): THESE INHIBITORS
EFFECTIVELY DISABLE A KEY PROTEIN THAT
HIV REQUIRES TO REPLICATE.
• PROTEASE INHIBITORS (PIS): THIS INHIBITOR
DISABLES THE PROTEIN KNOWN AS
PROTEASE, ANOTHER KEY BUILDING BLOCK
REQUIRED BY HIV TO REPLICATE.
• ENTRY/FUSION INHIBITORS: UNLIKE THE
PREVIOUSLY MENTIONED DRUG THERAPIES,
THIS INHIBITOR BLOCKS THE VIRUS’S ABILITY
TO ENTER THE BODY’S CD4 CELLS.
• INTEGRASE INHIBITORS: ONCE HIV HAS
PENETRATED A CD4 CELL, IT INSERTS
GENETIC MATERIAL INTO THE CELLS WITH
THE ASSISTANCE OF A PROTEIN KNOWN AS
INTEGRASE. THIS INHIBITOR BLOCKS THE
VIRUS’S ABILITY TO COMPLETE THIS CRUCIAL
REPLICATION STEP.
SIDE EFFECTS
Aids.gov.
(2017). Vaccines.
[online]
ELISA TEST
The Enzyme-Linked Immunosorbent Assay
(ELISA) is a technique used to detect
antibodies or infectious agents in a sample.
An ELISA test may be used to diagnose: